Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment
- 1 August 2006
- journal article
- review article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 82 (4) , 269-271
- https://doi.org/10.1136/sti.2005.017368
Abstract
The evidence that Mycoplasma genitalium is a sexually transmitted pathogen is virtually incontrovertible based on both the concordance rates among partners and on DNA typing showing the same sequence type among partners in contrast to unrelated M genitalium positive patients. The implications that this has for the screening, testing, and treatment of patients is less certain however. Which tests are the most sensitive and specific, what samples are most appropriate, who should be tested, what treatment is best and how should partners be managed?Keywords
This publication has 21 references indexed in Scilit:
- Use of TaqMan 5′ Nuclease Real-Time PCR for Quantitative Detection of Mycoplasma genitalium DNA in Males with and without Urethritis Who Were Attendees at a Sexually Transmitted Disease ClinicJournal of Clinical Microbiology, 2004
- Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseasesJournal of the European Academy of Dermatology and Venereology, 2003
- Mycoplasma genitalium attaches to human spermatozoaHuman Reproduction, 2003
- Mucopurulent Cervicitis andMycoplasma genitaliumThe Journal of Infectious Diseases, 2003
- Mycoplasma genitalium - an up-dateInternational Journal of STD & AIDS, 2002
- Association between Mycoplasma genitalium and acute endometritisThe Lancet, 2002
- Sexual behaviour in Britain: partnerships, practices, and HIV risk behavioursThe Lancet, 2001
- Serological investigation of Mycoplasma genitalium in infertile womenHuman Reproduction, 2001
- The role of Mycoplasma genitalium in non-gonococcal urethritisSexually Transmitted Infections, 2001
- A double‐blind, randomized, controlled multicentre study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of ageBJU International, 1999